Introducing the New Kid on the Block to Treat Depression: “Brintellix”

Introducing the New Kid on the Block to Treat Depression: “Brintellix”.

October 1, 2013-Takeda Pharmaceuticals has just released their latest FDA-approved medication to treat adults with Major Depressive Disorder called “Brintellix” with the generic name of “Vorioxetine”. It is available in 5mg, 10mg, and 20mg tablets. It works on Serotonin receptors, which means that it is a cousin of antidepressants such as Paxil, Prozac, Celexa, Lexapro, and Viibryd.

By Dr. Terra Caudill